Quest Diagnostics Incorporated (NYSE:DGX) Q4 2023 Earnings Call Transcript February 1, 2024 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.15, expectations were $2.14. Quest Diagnostics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Quest Diagnostics Fourth […]
Operator: Welcome to the Quest Diagnostics Second Quarter 2023 Conference Call. At the request of the company, this call is being recorded. [Operator Instructions].
Quest Diagnostics to Discuss Strategic Priorities to Drive Growth and Create Shareholder Value at 2023 Investor Day streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
SECAUCUS, N.J., April 22, 2021 /PRNewswire/ Quest Diagnostics Incorporated (NYSE: DGX), the world s leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2021. Quest had a very strong first quarter, with our base business continuing its recovery to near pre-pandemic levels, said Steve Rusckowski, Chairman, CEO and President, Quest Diagnostics. Contributions from acquisitions and Professional Lab Services relationships accelerated growth in the base business and helped offset the reduction in demand for COVID-19 testing, which was in line with industry trends. In March, for the first time since the pandemic began, monthly organic revenue in the base business grew versus our 2019 baseline. As we noted at our recent Investor Day, Quest is well positioned to grow as the U.S. exits the pandemic and people return to normal activities and address the routine care issues th